| Use of empiric antimicrobial therapy in neutropenic fever CS Tam, M O'Reilly, D Andresen, S Lingaratnam, A Kelly, K Burbury, ... Internal medicine journal 41 (1b), 90-101, 2011 | 87 | 2011 |
| Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs K Thursky, S Lingaratnam, J Jayarajan, GM Haeusler, B Teh, M Tew, ... BMJ open quality 7 (3), e000355, 2018 | 62 | 2018 |
| Use of antibacterial prophylaxis for patients with neutropenia MA Slavin, S Lingaratnam, L Mileshkin, DL Booth, MJ Cain, DS Ritchie, ... Internal medicine journal 41 (1b), 102-109, 2011 | 61 | 2011 |
| Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011 S Lingaratnam, MA Slavin, B Koczwara, JF Seymour, J Szer, C Underhill, ... Internal medicine journal 41 (1b), 75-81, 2011 | 45 | 2011 |
| Epidemiology of invasive fungal disease in lymphoproliferative disorders JC Teng, MA Slavin, BW Teh, SM Lingaratnam, MR Ananda-Rajah, ... Haematologica 100 (11), e462, 2015 | 44 | 2015 |
| Use of risk stratification to guide ambulatory management of neutropenic fever LJ Worth, S Lingaratnam, A Taylor, AM Hayward, S Morrissey, J Cooney, ... Internal medicine journal 41 (1b), 82-89, 2011 | 44 | 2011 |
| A ustralian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel M Alexander, J King, A Bajel, C Doecke, P Fox, S Lingaratnam, JD Mellor, ... Internal medicine journal 44 (10), 1018-1026, 2014 | 41 | 2014 |
| Developing a performance data suite to facilitate lean improvement in a chemotherapy day unit S Lingaratnam, D Murray, A Carle, SW Kirsa, R Paterson, D Rischin Journal of Oncology Practice 9 (4), e115-e121, 2013 | 41 | 2013 |
| The disease and economic burden of neutropenic fever in adult patients in Australian cancer treatment centres 2008: analysis of the Victorian Admitted Episodes Dataset S Lingaratnam, KA Thursky, MA Slavin, SW Kirsa, CA Bennett, LJ Worth Internal medicine journal 41 (1b), 121-129, 2011 | 37 | 2011 |
| Late‐onset Pneumocystis jirovecii pneumonia post–fludarabine, cyclophosphamide and rituximab: implications for prophylaxis GM Haeusler, MA Slavin, JF Seymour, S Lingaratnam, BW Teh, CS Tam, ... European journal of haematology 91 (2), 157-163, 2013 | 35 | 2013 |
| An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009 S Lingaratnam, MA Slavin, L Mileshkin, B Solomon, K Burbury, ... Internal medicine journal 41 (1b), 110-120, 2011 | 30 | 2011 |
| A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies S Maleki, M Alexander, T Fua, C Liu, D Rischin, S Lingaratnam Journal of Oncology Pharmacy Practice 25 (1), 130-139, 2019 | 29 | 2019 |
| Fluoroquinolone prophylaxis: a word of caution S Lingaratnam, KA Thursky, MA Slavin Leukemia & Lymphoma 52 (1), 5-6, 2011 | 28 | 2011 |
| A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment S Lingaratnam, LJ Worth, MA Slavin, CA Bennett, SW Kirsa, JF Seymour, ... Australian Health Review 35 (4), 491-500, 2011 | 26 | 2011 |
| Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: Clinical significance of quantitative polymerase chain reaction BW Teh, FA Azzato, SM Lingaratnam, KA Thursky, MA Slavin, LJ Worth Sabouraudia 52 (4), 427-432, 2014 | 17 | 2014 |
| A controlled before and after study to evaluate a patient and health professional partnership model towards effective medication reconciliation S Lingaratnam, S Aranda, T Pearce, S Kirsa Journal of Oncology Pharmacy Practice 19 (1), 48-56, 2013 | 13 | 2013 |
| A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel M Alexander, J King, S Lingaratnam, J Byrne, K Macmillan, A Mollo, ... Journal of Oncology Pharmacy Practice 22 (2), 219-227, 2016 | 12 | 2016 |
| Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis SM Lingaratnam, MA Slavin, KA Thursky, BW Teh, GM Haeusler, ... Leukemia & Lymphoma 56 (1), 157-162, 2015 | 12 | 2015 |
| Thromboprophylaxis among A ustralasian colorectal surgeons P Smart, K Burbury, S Lingaratnam, AC Lynch, J Mackay, A Heriot ANZ Journal of Surgery 83 (9), 646-650, 2013 | 12 | 2013 |
| Oral pristinamycin for the treatment of resistant Gram-positive infections in patients with cancer: Evaluation of clinical outcomes JC Teng, SM Lingaratnam, JA Trubiano, KA Thursky, MA Slavin, LJ Worth International journal of antimicrobial agents 47 (5), 391-396, 2016 | 9 | 2016 |
Professor Karin ThurskyRoyal Melbourne Hospital, Peter MacCallum Cancer Centre, University of MelbourneVerificeret mail på mh.org.au
